✦ LIBER ✦

Pamidronate infusions as single-agent therapy for bone metastases: A phase II trial in patients with breast cancer

✍ Scribed by C.T. Tyrrell; P.P. Bruning; F. May-Levin; C. Rose; L. Mauriac; M. Soukop; J.M. Ford

Book ID: 116166559
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 635 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00469-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delayed progression of bone metastases w

Delayed progression of bone metastases with bisphosphonate therapy: a randomised phase III trial with intravenous Aredia (pamidronate disodium) in breast cancer patients

✍ P.F. Conte; J. Latreille; L. Mauriac; L. Koliren; F. Calabresi; J.M. Ford 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Gemcitabine as First-Line Therapy in Pat

Gemcitabine as First-Line Therapy in Patients with Metastatic Breast Cancer: A Phase II Trial

✍ Blackstein, M.; Vogel, C.L.; Ambinder, R.; Cowan, J.; Iglesias, J.; Melemed, A. 📂 Article 📅 2002 🏛 S. Karger AG 🌐 English ⚖ 177 KB

Everolimus as treatment for breast cance

Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study

✍ Maass, Nicolai; Harbeck, Nadia; Mundhenke, Christoph; LerchenmÃ¼ller, Christian; 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 313 KB

PP-8-8 Reduction of skeletal related com

PP-8-8 Reduction of skeletal related complications in breast cancer patients with osteolytic bone metastases receiving hormone therapy, by monthly pamidronate sodium (AREDIA®) infusion

✍ R. Theriault; A. Upton; R. Leff; S. Gluck; J. Stewart; S. Costello; J. Simeone; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 179 KB

704 - Phase II studies of two trial regi

704 - Phase II studies of two trial regimens of topotecan as second-line single agent therapy in advanced breast cancer

✍ D. Spaëth; J. Bonneterre; M. Marty; D. Khayat; T. Facchini; T. Conroy 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Randomized Phase II Trial of Denosumab i

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

✍ Fizazi, K.; Lipton, A.; Mariette, X.; Body, J.-J.; Rahim, Y.; Gralow, J. R.; Gao 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 235 KB